Feeds:
Posts
Comments

Archive for the ‘VOC – Volatile Organic Compounds as BioMarkers’ Category

VOC – Biomarkers for Disease Diagnosis: Sniffing Out Cancer: Israeli Prof. Finds Diseases Like Cancer And Parkinson’s Can Be Detected On The Breath

Posted in Biomarkers & Medical Diagnostics, VOC - Volatile Organic Compounds as BioMarkers on January 19, 2017| Leave a Comment »

VOC – Biomarkers for Disease Diagnosis: Sniffing Out Cancer: Israeli Prof. Finds Diseases Like Cancer And Parkinson’s Can Be Detected On The Breath

Reporter: Aviva Lev-Ari, PhD, RN

 

VOC – Volatile Organic Compounds as BioMarkers.

voc

Image Source: http://nocamels.com/2017/01/disease-detection-smelling-breath/?utm_source=activetrail&utm_medium=email&utm_campaign=nc19/1/17

VIEW VIDEO

http://nocamels.com/2017/01/disease-detection-smelling-breath/?utm_source=activetrail&utm_medium=email&utm_campaign=nc19/1/17

Sniffing Out Cancer: Israeli Prof. Finds Diseases Like Cancer And Parkinson’s Can Be Detected On The Breath

by Yonatan Sredni, NoCamels January 16, 2017 

What if detecting cancer was as easy as breathing in and out? According to the results of a recent study, it is.

An international team of 56 researchers in five countries has confirmed that different diseases are characterized by different “chemical signatures” identifiable in breath samples.

The findings by the team led by Israel’s Professor Hossam Haick of the Technion-Israel Institute of Technology were published recently in ACS Nano.

SEE ALSO: Revolutionary Device Detects Deadly Diseases, Cancer, On The Breath

Although diagnostic techniques based on breath samples have been demonstrated in the past, until now there has not been scientific proof that different and unrelated diseases are characterized by distinct chemical breath signatures. Also, technologies developed to date for this type of diagnosis have been limited to detecting a small number of diseases.

17 diseases, 13 shared chemical components

The study of more than 1,400 patients included 17 different and unrelated diseases: lung cancer, colorectal cancer, head and neck cancer, ovarian cancer, bladder cancer, prostate cancer, kidney cancer, stomach cancer, Crohn’s disease, ulcerative colitis, irritable bowel syndrome, Parkinson’s disease (two types), multiple sclerosis, pulmonary hypertension, preeclampsia and chronic kidney disease. Samples were collected between January 2011 and June 2014 from 14 departments at nine medical centers in five countries: Israel, France, the USA, Latvia and China.

The researchers tested the chemical composition of the breath samples using an accepted analytical method (mass spectrometry). They discovered that all 17 of the diseases contained the same 13 chemical components, albeit in different compositions.

SOURCE

http://nocamels.com/2017/01/disease-detection-smelling-breath/?utm_source=activetrail&utm_medium=email&utm_campaign=nc19/1/17

Read Full Post »

Lung cancer breathalyzer trialed in the UK

Posted in VOC - Volatile Organic Compounds as BioMarkers on December 31, 2013| Leave a Comment »

Lung cancer breathalyzer trialed in the UK

Reporter: Aviva Lev-Ari, PhD, RN

Updated on 7/26/2022

VOC – Biomarkers for Disease Diagnosis: Sniffing Out Cancer: Israeli Prof. Finds Diseases Like Cancer And Parkinson’s Can Be Detected On The Breath

Reporter: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/category/biomarkers-medical-diagnostics/voc-volatile-organic-compounds-as-biomarkers/

See on Scoop.it – Cardiovascular and vascular imaging

With lung cancer survival rates greatly improved by early detection, we’ve seen a number of efforts to develop a better way to detect the disease in its early stages. So-called lung cancer breathalyzers are one technology being developed by a number of research teams, including one from the University of Huddersfield in the UK, which plans to trial a breathalyzer device in pharmacies.

 

The project to develop the device, which is taking place over three years, involves researching a lung cancer “biomarker signature” that is detectable in breath. Previous studies have already shown that carbon-based sensors embedded with gold nanoparticles and even dogs can detect chemicals in the breath indicating the presence of the disease in the lungs.

See on www.gizmag.com

Read Full Post »